Larvol Delta - LILRB4-START-Cells-in-the-Treatment-of-RelapsedRefractory-Acute-Myeloid-Leukemia

YTS104 - BriSTAR Immunotech, Beijing Qingyi Taike Pharma

cyclophosphamide - Generic mfg.

http://clinicaltrials.gov/ct2/show/NCT05548088

Sep 21, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev